Search

everythinglearnresearchcommunity

for

Search:↓

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

The FDA rejected a testosterone drug again due to safety concerns.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Polymers increased skin permeation and stability of steroid hormones in liposomal formulations.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Oral contraceptives can help manage acne by reducing androgen levels.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

Ethosomes can safely and effectively deliver various drugs deep into the skin.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Diet changes hormone levels in pregnant ewes by affecting metabolism, not placental synthesis.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Fetal environments contain various chemicals that may disrupt hormones.

The FDA did not approve a testosterone drug because of safety concerns.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Injection contraception has more negative side effects than hormonal pills.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

New progesterone-based compounds can block male hormones.

Some birth control pills increase young women's risk of blood clots more than others.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.